[HTML][HTML] Results of the CAPSID randomized trial for high-dose convalescent plasma in patients with severe COVID-19

…, M Bentz, S Zinn, G Paul, J Kalbhenn… - The Journal of …, 2021 - Am Soc Clin Investig
BACKGROUND COVID-19 convalescent plasma (CCP) has been considered a treatment
option for COVID-19. This trial assessed the efficacy of a neutralizing antibody containing high-…

[HTML][HTML] In-hospital and 6-month outcomes in patients with COVID-19 supported with extracorporeal membrane oxygenation (EuroECMO-COVID): a multicentre …

…, DL Staudacher, F Beyersdorf, J Kalbhenn… - The Lancet …, 2023 - thelancet.com
Background Extracorporeal membrane oxygenation (ECMO) has been widely used in patients
with COVID-19, but uncertainty remains about the determinants of in-hospital mortality …

Acquired von Willebrand syndrome and impaired platelet function during venovenous extracorporeal membrane oxygenation: Rapid onset and fast recovery

J Kalbhenn, A Schlagenhauf, S Rosenfelder… - The Journal of Heart and …, 2018 - Elsevier
Background Bleeding contributes to the high mortality of venovenous extracorporeal membrane
oxygenation (vvECMO). The development of acquired von Willebrand syndrome (AVWS…

Early diagnosis of acquired von Willebrand Syndrome (AVWS) is elementary for clinical practice in patients treated with ECMO therapy

J Kalbhenn, R Schmidt, L Nakamura… - … of atherosclerosis and …, 2015 - jstage.jst.go.jp
… Kalbhenn1, Rene Schmidt1, 2, Lea Nakamura3, Johannes Schelling3, Simone Rosenfelder3
and Barbara Zieger3 Johannes Kalbhenn and Rene Schmidt contributed equally to this …

[HTML][HTML] COVID-19 in-hospital mortality and mode of death in a dynamic and non-restricted tertiary care model in Germany

S Rieg, M Von Cube, J Kalbhenn, S Utzolino… - PloS one, 2020 - journals.plos.org
Background Reported mortality of hospitalised Coronavirus Disease-2019 (COVID-19)
patients varies substantially, particularly in critically ill patients. So far COVID-19 in-hospital …

Venovenous extracorporeal membrane oxygenation with prophylactic subcutaneous anticoagulation only: an observational study in more than 60 patients

K Krueger, A Schmutz, B Zieger, J Kalbhenn - Artificial Organs, 2017 - Wiley Online Library
Extracorporeal lung support and therapeutic anticoagulation are dogmatically linked for
most clinicians in fear of clotting of the extracorporeal circuit. In the last decade, however, we …

[HTML][HTML] Diagnosing capillary leak in critically ill patients: development of an innovative scoring instrument for non-invasive detection

…, C Wunder, S Utzolino, H Buerkle, J Kalbhenn… - Annals of intensive …, 2021 - Springer
Background The concomitant occurrence of the symptoms intravascular hypovolemia, peripheral
edema and hemodynamic instability is typically named Capillary Leak Syndrome (CLS) …

[HTML][HTML] Comparison of different anticoagulation strategies for renal replacement therapy in critically ill patients with COVID-19: a cohort study

…, E Neumann-Haefelin, PM Biever, G Walz, J Kalbhenn… - BMC nephrology, 2020 - Springer
Background Critically ill coronavirus disease 2019 (COVID-19) patients have a high risk of
acute kidney injury (AKI) that requires renal replacement therapy (RRT). A state of …

[HTML][HTML] Acquired von Willebrand syndrome and platelet function defects during extracorporeal life support (mechanical circulatory support)

A Schlagenhauf, J Kalbhenn, U Geisen… - …, 2020 - thieme-connect.com
Patients with ventricular assist devices (VADs) and extracorporeal membrane oxygenation (ECMO)
suffer from an increased risk for thromboembolic events as well as for hemorrhages. …

[HTML][HTML] Bleeding during veno-venous ECMO: prevention and treatment

J Kalbhenn, B Zieger - Frontiers in Medicine, 2022 - frontiersin.org
Venovenous extracorporeal membrane oxygenation (vvECMO) has become a routine
treatment for severe lung failure in specialized centers. Spontaneous bleeding complications, …